Latest news
https://amr-accelerator.eu/wp-content/uploads/2023/11/AMR-Accelerator_square-3-e1716812644571.png
200
250
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2026-01-19 08:00:542026-01-22 12:37:25The COMBINE pneumonia model
https://amr-accelerator.eu/wp-content/uploads/2024/04/Asset-1.png
218
229
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-11-18 08:50:072025-11-18 10:57:24AMR Accelerator Calls for Data
https://amr-accelerator.eu/wp-content/uploads/2025/11/GNA-NOW-interview.png
250
800
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-11-18 07:55:122025-11-17 16:14:06Pedro Henrique Quintela: Translating Discovery to Impact
https://amr-accelerator.eu/wp-content/uploads/2025/11/GNA-NOW-interview.png
250
800
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-11-18 07:52:362025-11-17 16:13:48Marie Attwood: Advancing In Vitro Modelling in AMR Research
https://amr-accelerator.eu/wp-content/uploads/2022/02/primavera-1.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-10-13 11:13:102025-11-05 11:14:4513/10/25 – PrIMAVeRa partners at 6th ESCMID Conference on Vaccines
https://amr-accelerator.eu/wp-content/uploads/2021/10/unite4tb-4.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-10-09 11:09:322025-11-05 11:10:3309/10/25 – UNITE4TB Expert Interview Series CompleteInterviews
https://amr-accelerator.eu/wp-content/uploads/2025/11/GNA-NOW-interview.png
250
800
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-11-18 07:55:122025-11-17 16:14:06Pedro Henrique Quintela: Translating Discovery to Impact
https://amr-accelerator.eu/wp-content/uploads/2025/11/GNA-NOW-interview.png
250
800
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-11-18 07:52:362025-11-17 16:13:48Marie Attwood: Advancing In Vitro Modelling in AMR Research
https://amr-accelerator.eu/wp-content/uploads/2025/04/COMBINE-interview.png
250
800
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2025-04-28 14:46:392025-05-14 12:26:10Carina Sofia Matias: Setting the Standard for Infection ModelsFrom the partners
https://amr-accelerator.eu/wp-content/uploads/2022/01/Partner_PrIMAVeRa_0000_ares.jpg
500
500
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2022-07-26 14:06:272023-07-28 14:06:3726/07/22 – OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
https://amr-accelerator.eu/wp-content/uploads/2022/07/Evotec.png
2000
2000
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2022-07-06 14:09:282023-07-28 14:53:2106/07/22 – Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
https://amr-accelerator.eu/wp-content/uploads/2022/04/NICE.png
2000
2000
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2022-04-12 13:56:112023-07-28 14:54:0512/04/22 – NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance
https://amr-accelerator.eu/wp-content/uploads/2022/03/Uni-Dundee.png
2000
2000
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2022-03-04 14:00:462023-07-28 14:54:4224/03/22 – Post-Covid TB warning as DDU receives $5 million award
https://amr-accelerator.eu/wp-content/uploads/2019/04/LogoSantPau.png
756
756
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2022-02-01 14:04:192023-07-28 14:04:3401/02/22 – ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner
https://amr-accelerator.eu/wp-content/uploads/2023/07/Uni-Oxford-UCL.png
2000
2000
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2021-11-02 13:50:102023-07-28 13:50:2102/11/21 – Antibiotic Research UK awards grants to fund research worth £200,000
ERA4TB Newsletter – September 2022
UNITE4TB Newsletter – September 2022
RespiriNTM & -TB Newsletter – May 2022
AMR ACCELERATOR NEWSLETTER – MAY 2022
ERA4TB Newsletter – February 2022
AMR Accelerator Newsletter – November 2021